Skip to main content
Premium Trial:

Request an Annual Quote

School is in Session

There are about 75,000 genetics tests on the market, and doctors have no idea what to do with them all, says The Verge. Indeed, a recent study of primary care docs in New York showed that only 14 percent of them were comfortable interpreting results from genetic tests.

Meanwhile, 10 new genetic tests enter the market every day, and they're rapidly becoming a part of routine care, the article notes, reporting that the CEO of Pennsylvania health care provider Geisinger recently announced that its doctors will now routinely offer patients DNA sequencing.

If major health care providers are planning to adopt genetic screening as part of their routine care, then they need to train their doctors to understand "which tests to pick, how they work, and how to interpret the results," The Verge says. "Otherwise, overwhelmed doctors may order the wrong test, or they may misinterpret the result — confusing patients and potentially leading to wrong diagnoses or false positives."

But that's not enough, either. Doctors also need to be able to tell patients what the pros and cons are of getting their DNA sequenced. Genetic screening sometimes reveals difficult information, such as whether a patient could develop a disease like Huntington's, The Verge says. And research shows that this type of genetic data can sometimes change how people live their lives.

"The test holds a lot of information and potential for both good and bad, and that means as they become more widespread, all health care providers need to be responsible for implementing these plans," the article adds.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.